Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-08

Clinical Trial Update: Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in Jordan

View source ↗

Summary

This clinical trial update reports completion of a safety study evaluating generic mycophenolate mofetil as prophylaxis against acute rejection in de novo kidne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Hikma Pharmaceuticals LLC | Conditions: Acute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant | Status: COMPLETED